Clindamycin Phosphate And Tretinoin Gel 1.2%/0.025% Gel
Product Images NDC 21922-050

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clindamycin Phosphate And Tretinoin Gel 1.2%/0.025% (NDC 21922-050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Encube Ethicals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Cart-lab-30gm (Cart Lab 30gm)

Cart-lab-30gm (Cart Lab 30gm)
Description: This text provides information about a topical medication with the National Drug Code (NDC) 21922-050-05. The medication contains Clindamycin Phosphate and Tretinoin in a concentration of 1.2%/0.025%. It is manufactured by Encube Ethicals Pvt. Ltd. in Goa, India, and distributed by Encube Ethicals, Inc. in Durham, USA. The usual dosage and precautions are mentioned, including avoiding contact with the eyes, mouth, and mucous membranes, as well as keeping the medication out of reach of children. The text also describes the composition of the product and advises storing it at room temperature. The label includes a contact number for reporting any side effects. The text concludes with some batch details, such as expiration date and lot number.*
FDA Label Image

Cart-lab-60gm (Cart Lab 60gm)

Cart-lab-60gm (Cart Lab 60gm)
Description not available.*
FDA Label Image

Str-clinda (Str Clinda)

Str-clinda (Str Clinda)
FDA Label Image

Str-treti (Str Treti)

Str-treti (Str Treti)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.